EP3785683A1 — Drug eluting ocular implant
Assigned to Dose Medical Corp · Expires 2021-03-03 · 5y expired
What this patent protects
A drug delivery ocular implant (53), comprising an outer shell (54); a cap (53a) configured to be joined to the outer shell at one end to form a lumen (58), the lumen configured to contain a drug (62), the cap having at least one region of drug release (56); and a permeable or se…
USPTO Abstract
A drug delivery ocular implant (53), comprising an outer shell (54); a cap (53a) configured to be joined to the outer shell at one end to form a lumen (58), the lumen configured to contain a drug (62), the cap having at least one region of drug release (56); and a permeable or semi-permeable material (60) covering the at least one region of drug release, the permeable or semi-permeable material being permeable or semi-permeable to the drug.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.